Villano JL, Koshy M, Shaikh H et al (2011) Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer 105:1414–1418

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ostrom QT, Price M, Neff C et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol 24:v1–v95

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ferreri AJM, Cwynarski K, Pulczynski E et al (2022) Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial. Leukemia 36:1870–1878

Article  PubMed  CAS  Google Scholar 

Swerdlow SH, Campo E, Harris NL et al (eds) (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th Edition. IARC, Lyon

Google Scholar 

Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood 140:1229–1253

Article  PubMed  PubMed Central  CAS  Google Scholar 

WHO Classification of Tumours Editorial Board (2022) Haematolymphoid tumours. International Agency for Research on Cancer, Lyon (France). (WHO classification of tumours series, 5th ed; vol 11). [Internet; beta version ahead of print] https://tumourclassification.iarc.who.int/chapters/63. Accessed 4 June 2023

Pillai RK, Sathanoori M, Van Oss SB et al (2013) Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Am J Surg Pathol 37:323–332

Article  PubMed  Google Scholar 

Nosrati A, Monabati A, Sadeghipour A et al (2019) MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type. Ann Hematol 98:169–173

Article  PubMed  CAS  Google Scholar 

Pina-Oviedo S, Bellamy WT, Gokden M (2020) Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases. Ann Diagn Pathol 48:151610

Article  PubMed  Google Scholar 

Cady FM, O’Neill BP, Law ME et al (2008) Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. J Clin Oncol 26:4814–4819

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brunn A, Nagel I, Montesinos-Rongen M et al (2013) Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas. Acta Neuropathol 126:603–605

Article  PubMed  Google Scholar 

Lindsley RC, LaCasce AS (2012) Biology of double-hit B-cell lymphomas. Curr Opin Hematol 19:299–304

Article  PubMed  PubMed Central  Google Scholar 

Friedberg JW (2012) Double-hit diffuse large B-cell lymphoma. J Clin Oncol 30:3439–3443

Article  PubMed  CAS  Google Scholar 

Grommes C, DeAngelis LM (2017) Primary CNS lymphoma. J Clin Oncol 35:2410–2418

Article  PubMed  PubMed Central  CAS  Google Scholar 

Parkhi M, Chatterjee D, Radotra BD et al (2023) Double-hit and double-expressor primary central nervous system lymphoma: Experience from North India of an infrequent but aggressive variant. Surg Neurol Int 14:172

Article  PubMed  PubMed Central  Google Scholar 

Cucco F, Barrans S, Sha C et al (2020) Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit. Leukemia 34:1329–1341

Article  PubMed  CAS  Google Scholar 

Li J, Zhao S, Wang J et al (2016) CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases. Tumour Biol 37:3619–3637

Article  PubMed  CAS  Google Scholar 

Li YJ, Li ZM, Rao HL et al (2012) CD20-negative de novo diffuse large B-cell lymphoma in HIV-negative patients: a matched case-control analysis in a single institution. J Transl Med 10:84

Article  PubMed  PubMed Central  Google Scholar 

Setiawan SA, Liu WZ, Weng PW et al (2023) Synergistic disruption of BTK and BCL-2 causes apoptosis while inducing ferroptosis in double-hit lymphoma. Eur J Pharmacol 943:175526

Article  PubMed  CAS  Google Scholar 

Jahnke K, Thiel E, Martus P et al (2006) Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neurooncol 80:159–165

Article  PubMed  Google Scholar 

Malani R, Bhatia A, Wolfe J et al (2019) Staging identifies non-CNS malignancies in a large cohort with newly diagnosed lymphomatous brain lesions. Leuk Lymphoma 60:2278–2282

Article  PubMed  PubMed Central  Google Scholar 

Brandt A, Matschke J, Fehrle W et al (2019) A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells. Leuk Lymphoma 60:334–340

Article  PubMed  CAS  Google Scholar 

Margold M, Seidel S, Kowalski T et al (2021) The value of bone marrow biopsy for staging of patients with primary CNS lymphoma. Neuro Oncol 23:2076–2084

Article  PubMed  PubMed Central  Google Scholar 

Jelicic J, Hansen DL, Carlsen SS et al (2023) Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era. Ann Hematol 102:1897–1905

Article  PubMed  PubMed Central  Google Scholar 

Khalil NCN, Iwaiwi BI, Hammad S et al (2023) A necrotic primary central nervous system lymphoma in immunocompetent patient with MYC and BCL6 rearrangements (double-hit lymphoma): a case report. Oxf Med Case Rep 2023:omad026

Article  Google Scholar 

O’Neill BP, Dinapoli RP, Kurtin PJ et al (1995) Occult systemic non-Hodgkin’s lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough? J Neurooncol 25:67–71

Article  PubMed  Google Scholar 

Ferreri AJ, Reni M, Zoldan MC et al (1996) Importance of complete staging in non-Hodgkin’s lymphoma presenting as a cerebral mass lesion. Cancer 77:827–833

Article  PubMed  CAS  Google Scholar 

Mohile NA, Deangelis LM, Abrey LE (2008) The utility of body FDG PET in staging primary central nervous system lymphoma. Neuro Oncol 10:223–228

Article  PubMed  PubMed Central  Google Scholar 

Kaddu-Mulindwa D, Altmann B, Held G et al (2021) FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials. Eur J Nucl Med Mol Imaging 48:3550–3559

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen-Liang TH, Martin-Santos T, Jerez A et al (2015) The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients. Am J Hematol 90:686–690

Article  PubMed  CAS  Google Scholar